Related Experiment Video
Updated: Mar 9, 2026

07:22
Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
Published on: January 12, 2024
4.7K
Analyzing Therapeutic Change Using Modified Brinley Plots: History, Construction, and Interpretation
1University of Canterbury.
Behavior Therapy
|January 13, 2017
Summary
Modified Brinley plots visually display individual therapy outcomes, aiding interpretation of treatment effectiveness and clinical significance. These plots enhance therapy outcome research by illustrating individual change alongside group data.
Area of Science:
- Psychology
- Clinical Psychology
- Therapy Outcome Research
Background:
- Brinley plots, used since 1965 for group mean data, were occasionally adapted for individual data between 1979-1995.
- Modified Brinley plots offer a visual method for analyzing individual participant changes in therapy outcome research.
Purpose of the Study:
- To review the history, construction, and interpretation of modified Brinley plots.
- To highlight their utility in therapy outcome research for assessing individual and group changes.
Main Methods:
- The paper reviews the methodology of constructing and interpreting modified Brinley plots.
- Key elements include using orthogonal axes with identical scales and origins to plot individual scores over time.
Main Results:
- Modified Brinley plots effectively display individual change, improvement/deterioration magnitude, outliers, and replication across cases.
- Interpretation is enhanced by integrating reliable change boundaries, clinical cutoffs, means, variances, confidence intervals, and effect sizes.
Conclusions:
- Modified Brinley plots provide direct insights into individual therapeutic change within a group context.
- They are valuable for assessing outcome replication, clinical significance, and complementing other analytical methods in therapy research.
More Related Videos
Related Concept Videos
Therapeutic Drug Monitoring: Affecting Factors
303
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
303
Regression Toward the Mean
7.3K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
7.3K

